ATXI · Avenue Therapeutics, Inc.
$0.26
+0.00 (+0.00%)
At close · Aug 17
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors individually and collectively cause substantial doubt about the Company's ability to continue as a going concern to exist within one year from the date of this report.”View the 10-Q filed Aug 7, 2026
Market Cap
$848,783
Shares
3.29M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.26
Open$0.26
Day$0.26–0.26
52W close$0.15–0.93
Avg vol 30d4K
Short int8K · 0.2% float · 1.0d
Short vol4%
DataApr 2024–Aug 2026
Filing10-Q · Aug 7
Raw chart and full-history price indicators begin at the captured split on Apr 26, 2024; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 7, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−51%
below
Price vs 50-day avg
−16%
below
RSI (14)
44
neutral
MACD trend
Negative
52-week position
14%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−22%
trailing
6-month return
−62%
trailing
YTD return
−62%
this year
Relative strength
−74%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-11% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.24% of float · ▲ +679.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
8 holders — near 3-yr low, contrarian setup
Squeeze score
38
low risk · 0–100
Fundamentals
EPS growth
+29%
Y/Y
Balance sheet
$2.9M
net cash
Quant / Vol
risk profile
Volatility
242%
annualized · 1-yr
Max drawdown
−84%
past year
ATR
23.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−51%
Bearish
Price vs 50-day avg
−16%
Bearish
RSI (14)
44
Neutral
MACD trend
Negative
Bearish
52-week position
14%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-11% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.24% of float · ▲ +679.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
8 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0
Now $0 · 14%
Range high $1
vs 200-day avg -51%
vs 50-day avg -16%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ATXI
this stock
Avenue Therapeutics, Inc.
|
$848,783 | -62.1% | — | — | 0.2% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +19.3% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +13.7% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.4% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +17.5% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
8
- % held
- 5.8%
- Net QoQ
- -4.9K sh
- Top holder
- Ikarian Capital, LLC
Held
Float
Short & Settlement
Financials
Performance
Raw-price comparisons begin at the captured split on Apr 26, 2024; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ATXI | +3.0% | -21.9% | -61.6% | -33.6% | -62.1% |
| SPY | -0.1% | +4.1% | +12.4% | +3.4% | +13.3% |
| vs SPY | +3.1% | -26.1% | -74.0% | -37.0% | -75.4% |